REGN5093-M114 Antibody
REGN5093-M114 is a bispecific ADC targeting dual MET epitopes, derived from the antibody davutamig and conjugated to a tubulin inhibitor. It has demonstrated potent inhibition of NSCLC cell proliferation in vitro and antitumor efficacy in mouse xenograft models, supporting its investigation in MET-driven cancers.
Product Specifications
Target
C-Met/HGFR, Antibody-Drug Conjugates (ADCs), Microtubule Associated
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2406-500 1x 500 µL
Bcl-X (Apoptosis Marker) (BCL2L1/2406), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681922-500 1x 500 µL
TPO (Thyroid Peroxidase) (Thyroid Marker) (TPO/1922), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 